Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma

Amit G. Singal, Jasmin A. Tiro, Jorge A. Marrero, Katharine McCallister, Caroline Mejias, Brian Adamson, Wendy Pechero Bishop, Noel O. Santini, Ethan A. Halm

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background & Aims Surveillance of patients with cirrhosis increases early detection of hepatocellular carcinoma (HCC) and prolongs survival. However, its effectiveness is limited by underuse, particularly among racial/ethnic minorities and individuals of low socioeconomic status. We compared the effectiveness of mailed outreach strategies, with and without patient navigation, in increasing the numbers of patients with cirrhosis undergoing surveillance for HCC in a racially diverse and socioeconomically disadvantaged cohort. Methods We performed a prospective study of patients with documented or suspected cirrhosis at a large safety-net health system from December 2014 through March 2016. Patients were assigned randomly (1:1:1) to groups that received mailed invitations for an ultrasound screening examination (n = 600), mailed invitations for an ultrasound screening examination and patient navigation (barrier assessment and motivational education for patients who declined screening; n = 600), or usual care (visit-based screening; n = 600). Patients who did not respond to outreach invitations within 2 weeks received up to 3 reminder telephone calls. The primary outcome was completion of abdominal imaging within 6 months of randomization. Results Baseline characteristics were similar among groups. Cirrhosis was documented, based on International Classification of Diseases, 9th revision, codes, for 79.6% of patients, and suspected, based on noninvasive markers of fibrosis, for 20.4%. In an intent-to-treat analysis, significantly greater proportions of patients who received the mailed invitation and navigation (47.2%) or the mailed invitation alone (44.5%) underwent HCC screening than patients who received usual care (24.3%) (P <.001 for both comparisons). However, screening rates did not differ significantly between outreach the outreach groups (P =.25). The effects of the outreach program were consistent in all subgroups, including Caucasian vs non-Caucasian race, documented vs suspected cirrhosis, Child–Pugh A vs B cirrhosis, and receipt of gastroenterology care. Conclusions In a prospective study, we found outreach strategies to double the percentage of patients with cirrhosis who underwent ultrasound screening for HCC. However, adding patient navigation to telephone reminders provided no significant additional benefit. ClinicalTrials.gov no: NCT02312817.

Original languageEnglish (US)
Pages (from-to)608-615.e4
JournalGastroenterology
Volume152
Issue number3
DOIs
StatePublished - Feb 1 2017

Fingerprint

Hepatocellular Carcinoma
Fibrosis
Patient Navigation
Telephone
Prospective Studies
International Classification of Diseases
Vulnerable Populations
Gastroenterology
Patient Education
Random Allocation
Social Class
Safety
Survival
Health

Keywords

  • Intervention
  • Liver Cancer
  • Prevention
  • Randomized Controlled Trial

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma. / Singal, Amit G.; Tiro, Jasmin A.; Marrero, Jorge A.; McCallister, Katharine; Mejias, Caroline; Adamson, Brian; Bishop, Wendy Pechero; Santini, Noel O.; Halm, Ethan A.

In: Gastroenterology, Vol. 152, No. 3, 01.02.2017, p. 608-615.e4.

Research output: Contribution to journalArticle

Singal, Amit G. ; Tiro, Jasmin A. ; Marrero, Jorge A. ; McCallister, Katharine ; Mejias, Caroline ; Adamson, Brian ; Bishop, Wendy Pechero ; Santini, Noel O. ; Halm, Ethan A. / Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma. In: Gastroenterology. 2017 ; Vol. 152, No. 3. pp. 608-615.e4.
@article{d9ae567e55b5471a97f987a825fb2b45,
title = "Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma",
abstract = "Background & Aims Surveillance of patients with cirrhosis increases early detection of hepatocellular carcinoma (HCC) and prolongs survival. However, its effectiveness is limited by underuse, particularly among racial/ethnic minorities and individuals of low socioeconomic status. We compared the effectiveness of mailed outreach strategies, with and without patient navigation, in increasing the numbers of patients with cirrhosis undergoing surveillance for HCC in a racially diverse and socioeconomically disadvantaged cohort. Methods We performed a prospective study of patients with documented or suspected cirrhosis at a large safety-net health system from December 2014 through March 2016. Patients were assigned randomly (1:1:1) to groups that received mailed invitations for an ultrasound screening examination (n = 600), mailed invitations for an ultrasound screening examination and patient navigation (barrier assessment and motivational education for patients who declined screening; n = 600), or usual care (visit-based screening; n = 600). Patients who did not respond to outreach invitations within 2 weeks received up to 3 reminder telephone calls. The primary outcome was completion of abdominal imaging within 6 months of randomization. Results Baseline characteristics were similar among groups. Cirrhosis was documented, based on International Classification of Diseases, 9th revision, codes, for 79.6{\%} of patients, and suspected, based on noninvasive markers of fibrosis, for 20.4{\%}. In an intent-to-treat analysis, significantly greater proportions of patients who received the mailed invitation and navigation (47.2{\%}) or the mailed invitation alone (44.5{\%}) underwent HCC screening than patients who received usual care (24.3{\%}) (P <.001 for both comparisons). However, screening rates did not differ significantly between outreach the outreach groups (P =.25). The effects of the outreach program were consistent in all subgroups, including Caucasian vs non-Caucasian race, documented vs suspected cirrhosis, Child–Pugh A vs B cirrhosis, and receipt of gastroenterology care. Conclusions In a prospective study, we found outreach strategies to double the percentage of patients with cirrhosis who underwent ultrasound screening for HCC. However, adding patient navigation to telephone reminders provided no significant additional benefit. ClinicalTrials.gov no: NCT02312817.",
keywords = "Intervention, Liver Cancer, Prevention, Randomized Controlled Trial",
author = "Singal, {Amit G.} and Tiro, {Jasmin A.} and Marrero, {Jorge A.} and Katharine McCallister and Caroline Mejias and Brian Adamson and Bishop, {Wendy Pechero} and Santini, {Noel O.} and Halm, {Ethan A.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1053/j.gastro.2016.10.042",
language = "English (US)",
volume = "152",
pages = "608--615.e4",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma

AU - Singal, Amit G.

AU - Tiro, Jasmin A.

AU - Marrero, Jorge A.

AU - McCallister, Katharine

AU - Mejias, Caroline

AU - Adamson, Brian

AU - Bishop, Wendy Pechero

AU - Santini, Noel O.

AU - Halm, Ethan A.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Background & Aims Surveillance of patients with cirrhosis increases early detection of hepatocellular carcinoma (HCC) and prolongs survival. However, its effectiveness is limited by underuse, particularly among racial/ethnic minorities and individuals of low socioeconomic status. We compared the effectiveness of mailed outreach strategies, with and without patient navigation, in increasing the numbers of patients with cirrhosis undergoing surveillance for HCC in a racially diverse and socioeconomically disadvantaged cohort. Methods We performed a prospective study of patients with documented or suspected cirrhosis at a large safety-net health system from December 2014 through March 2016. Patients were assigned randomly (1:1:1) to groups that received mailed invitations for an ultrasound screening examination (n = 600), mailed invitations for an ultrasound screening examination and patient navigation (barrier assessment and motivational education for patients who declined screening; n = 600), or usual care (visit-based screening; n = 600). Patients who did not respond to outreach invitations within 2 weeks received up to 3 reminder telephone calls. The primary outcome was completion of abdominal imaging within 6 months of randomization. Results Baseline characteristics were similar among groups. Cirrhosis was documented, based on International Classification of Diseases, 9th revision, codes, for 79.6% of patients, and suspected, based on noninvasive markers of fibrosis, for 20.4%. In an intent-to-treat analysis, significantly greater proportions of patients who received the mailed invitation and navigation (47.2%) or the mailed invitation alone (44.5%) underwent HCC screening than patients who received usual care (24.3%) (P <.001 for both comparisons). However, screening rates did not differ significantly between outreach the outreach groups (P =.25). The effects of the outreach program were consistent in all subgroups, including Caucasian vs non-Caucasian race, documented vs suspected cirrhosis, Child–Pugh A vs B cirrhosis, and receipt of gastroenterology care. Conclusions In a prospective study, we found outreach strategies to double the percentage of patients with cirrhosis who underwent ultrasound screening for HCC. However, adding patient navigation to telephone reminders provided no significant additional benefit. ClinicalTrials.gov no: NCT02312817.

AB - Background & Aims Surveillance of patients with cirrhosis increases early detection of hepatocellular carcinoma (HCC) and prolongs survival. However, its effectiveness is limited by underuse, particularly among racial/ethnic minorities and individuals of low socioeconomic status. We compared the effectiveness of mailed outreach strategies, with and without patient navigation, in increasing the numbers of patients with cirrhosis undergoing surveillance for HCC in a racially diverse and socioeconomically disadvantaged cohort. Methods We performed a prospective study of patients with documented or suspected cirrhosis at a large safety-net health system from December 2014 through March 2016. Patients were assigned randomly (1:1:1) to groups that received mailed invitations for an ultrasound screening examination (n = 600), mailed invitations for an ultrasound screening examination and patient navigation (barrier assessment and motivational education for patients who declined screening; n = 600), or usual care (visit-based screening; n = 600). Patients who did not respond to outreach invitations within 2 weeks received up to 3 reminder telephone calls. The primary outcome was completion of abdominal imaging within 6 months of randomization. Results Baseline characteristics were similar among groups. Cirrhosis was documented, based on International Classification of Diseases, 9th revision, codes, for 79.6% of patients, and suspected, based on noninvasive markers of fibrosis, for 20.4%. In an intent-to-treat analysis, significantly greater proportions of patients who received the mailed invitation and navigation (47.2%) or the mailed invitation alone (44.5%) underwent HCC screening than patients who received usual care (24.3%) (P <.001 for both comparisons). However, screening rates did not differ significantly between outreach the outreach groups (P =.25). The effects of the outreach program were consistent in all subgroups, including Caucasian vs non-Caucasian race, documented vs suspected cirrhosis, Child–Pugh A vs B cirrhosis, and receipt of gastroenterology care. Conclusions In a prospective study, we found outreach strategies to double the percentage of patients with cirrhosis who underwent ultrasound screening for HCC. However, adding patient navigation to telephone reminders provided no significant additional benefit. ClinicalTrials.gov no: NCT02312817.

KW - Intervention

KW - Liver Cancer

KW - Prevention

KW - Randomized Controlled Trial

UR - http://www.scopus.com/inward/record.url?scp=85010711876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010711876&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2016.10.042

DO - 10.1053/j.gastro.2016.10.042

M3 - Article

VL - 152

SP - 608-615.e4

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 3

ER -